Borealis is the first plastics producer to carry out third-party external audits for Operation Clean Sweep, an international initiative aimed at preventing pellet loss. (Borealis )
Belgium: Industry-Led Program

Plastics Producer Borealis Performs Pilot Audits for Zero Pellet Loss Certification Scheme

Operation Clean Sweep (OCS), a global initiative focusing on prevention of pellet loss is working on developing a unified and equitable certification scheme for pellet handlers across the entire value chain in order to achieve zero pellet loss. Under this scheme, audits will be carried out by accredited third parties to establish compliance with OCS requirements. In this background, Borealis has performed third-party external audits at two of its production locations in Kallo and Antwerp, Belgium which will be vital for finalizing the certification scheme.

Read on
The ZoneFlow Reactor Technology promises to provide a step-change improvement in the efficiency and carbon intensity of steam methane reforming for the production of hydrogen. (Business Wire)
Belgium: Low-Carbon Hydrogen

Major Breakthrough in Steam Methane Reforming

Honeywell has partnered with ZoneFlow Reactor Technologies to commercialize the ZoneFlow Reactor Technology, an innovative structured catalyst module used for the production of hydrogen. Claimed to be a revolutionary technology for steam methane reforming, it is capable of producing low-carbon hydrogen more efficiently and is also cost effective.

Read on
Lonza will gain worldwide access and sub-licensable rights to Codiak's high-throughput perfusion-based cGMP process for exosome manufacturing. (Lonza)
USA: Business Strategy

Lonza Takes Over Codiak BioSciences’ Exosome Manufacturing Facility in USA

Lonza has acquired Codiak BioSciences’ exosome manufacturing plant in Lexington, Massachusetts, USA and under the terms of the contract, Codiak will receive approximately 65 million dollars of in-kind manufacturing services for its clinical-stage programs and retain its pipeline of therapeutic candidates and exosome engineering and drug-loading technologies. Both the companies will also develop a Center of Excellence which will focus on exosome manufacturing and characterization technologies.

Read on